Due to a limited supply, we are unable to accept phone calls to schedule COVID-19 vaccinations.
For the most up-to-date information, please check our COVID-19 Vaccination Website.


Additional Coronavirus Updates >


Fox Chase Cancer Center News

October 30, 2020

DNA Repair Gene Mutations Found in Patients with Early Onset Renal Cancer

PHILADELPHIA (October 30, 2020) – Pathogenic variants in DNA damage response and repair (DDRR) genes have been identified in patients with early onset renal cancer, according to a recent study by researchers at Fox Chase Cancer Center.

October 26, 2020

Fox Chase Researchers Present Findings on Impact of Radiotherapy for Head and Neck Cancer on Time Off Work

PHILADELPHIA (October 29, 2020)—Researchers from Fox Chase Cancer Center have presented new data indicating that several factors, the most significant one being pain, are significantly associated with a reduction in the number of working days per week in patients who attempt to work while receiving radiation treatment for head and neck cancer (HNC).

October 26, 2020

Fox Chase Cancer Center to Participate in Virtual PurpleStride Philadelphia 2020

PHILADELPHIA (October 26, 2020)— Fox Chase Cancer Center is proud to support the Pancreatic Cancer Action Network (PanCAN) for PurpleStride Philadelphia 2020. Fox Chase will participate virtually with pancreatic cancer survivors, their loved ones, caregivers, and researchers on Saturday, November 7, 2020, to raise money for pancreatic cancer research and patient services.

October 26, 2020

Fox Chase Researchers Present Findings Comparing Radiation Therapies Show They Are Safe for Prostate Cancer Patients

PHILADELPHIA (October 26, 2020)—Researchers from Fox Chase Cancer Center have presented new data that shows that moderately hypofractionated photon and proton therapies are both safe for patients with low- or intermediate-risk prostate cancer.

October 23, 2020

Research and Philanthropy Combine to Find Potential New Target for Endometrial Cancers

PHILADELPHIA (October 23, 2020) – Researchers at Fox Chase Cancer Center have discovered a potential new target in the treatment of endometrial carcinoma, thanks in part to generous funding from Peggy’s Pathway for Women’s Cancer Care. The research was published recently in Molecular & Cellular Proteomics.

October 23, 2020

Fox Chase Researcher Carolyn Fang Promoted to Associate Director for Population Science

PHILADELPHIA (October 23, 2020)— Carolyn Y. Fang, PhD, professor and co-leader of the Cancer Prevention and Control Program at Fox Chase Cancer Center, has been promoted to the role of associate director for Population Science.

October 22, 2020

Fox Chase Researcher Erica Golemis Appointed Senior Editor for eLife

PHILADELPHIA (October 22, 2020)—Erica Golemis, PhD, deputy chief science officer and co-leader of the Molecular Therapeutics research program at Fox Chase Cancer Center, was recently appointed senior editor at eLife, an open-access, peer-reviewed journal.

October 20, 2020

Micro-Ultrasound Technology Could Be a Leap Forward for Prostate Cancer Patients

PHILADELPHIA (October 13, 2020)—Fox Chase Cancer Center has unveiled a new micro-ultrasound system that physicians say could change the way prostate cancer is diagnosed.


Connect with Fox Chase